candesartan has been researched along with Lupus Nephritis in 2 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Lupus Nephritis: Glomerulonephritis associated with autoimmune disease SYSTEMIC LUPUS ERYTHEMATOSUS. Lupus nephritis is histologically classified into 6 classes: class I - normal glomeruli, class II - pure mesangial alterations, class III - focal segmental glomerulonephritis, class IV - diffuse glomerulonephritis, class V - diffuse membranous glomerulonephritis, and class VI - advanced sclerosing glomerulonephritis (The World Health Organization classification 1982).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Recent immunosuppressive treatments for lupus nephritis have improved renal survival rate, however, there still exists lupus nephritis refractory to these treatments." | 1.33 | Antiproteinuric effect of ARB in lupus nephritis patients with persistent proteinuria despite immunosuppressive therapy. ( Kanda, H; Kubo, K; Mimura, T; Sato, K; Tateishi, S; Yamamoto, K; Yonezumi, A, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pérez de Lema, G | 1 |
| Mampaso, F | 1 |
| Schlöndorff, D | 1 |
| Kanda, H | 1 |
| Kubo, K | 1 |
| Tateishi, S | 1 |
| Sato, K | 1 |
| Yonezumi, A | 1 |
| Yamamoto, K | 1 |
| Mimura, T | 1 |
2 other studies available for candesartan and Lupus Nephritis
| Article | Year |
|---|---|
About the mechanisms of renoprotective effect of angiotensin inhibitors on lupus nephritis.
Topics: Angiotensins; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Lupus Nephritis; | 2004 |
Antiproteinuric effect of ARB in lupus nephritis patients with persistent proteinuria despite immunosuppressive therapy.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Biphenyl Compounds; Blood Pres | 2005 |